Super Micro Computer, Inc. - SMCI

SMCI Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
SMCI	-8.7	44.9	-46.0	-58.6	-71.3	-11.0	511.4	1128.6	663.3	2845.2
S&P 500	0.0	0.1	1.1	5.3	11.2	30.4	26.4	90.7	186.8	33405.7

Compare SMCI with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	SMCI
name	Super Micro Computer, Inc.
price	25.80
changes percentage	-8.74
change	-2.47
day low	24.82
day high	27.71
year high	122.90
year low	17.25
market cap	15107577000
price avg 50	39.07
price avg 200	70.48
exchange	NASDAQ
volume	95504609
avg volume	79729675
open	27.29
previous close	28.27
eps	2.01
pe	12.84
earnings announcement	2025-01-27T05:00:00.000+0000
shares outstanding	585565000
timestamp	2024-11-20 21:00:01

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 41.0%

Overall Quarterly Financial Health: 37.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001375365
revenue	14942854000	7123482000	109.77
gross profit	2111729000	1283012000	64.59
gross profit ratio	0.14	0.18	-21.54
research and development expenses	462926000	307260000	50.66
operating expenses	846037000	521870000	62.12
interest income	0	10491000	-100.00
interest expense	19352000	10491000	84.46
ebitda	1288409000	796046000	61.85
ebitdaratio	0.09	0.11	-19.69
operating income	1265692000	761142000	66.29
operating income ratio	0.08	0.11	-20.73
net income	1208149000	639998000	88.77
net income ratio	0.08	0.09	-10.01
eps	2.17	1.21	79.34

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 14,943 million in 2024 from 7,123 million in 2023 representing a change of 109.77%. This indicates a sales shrinking, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 846 million in 2024 from 522 million in 2023 representing a change of 62.12%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 1,288 million in 2024 from 796 million in 2023 representing a change of 61.85%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 1,266 million in 2024 from 761 million in 2023 representing a change of 66.29%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 1,208 million in 2024 from 640 million in 2023 representing a change of 88.77%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 2,112 million in 2024 from 1,283 million in 2023 representing a change of 64.59%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 463 million in 2024 from 307 million in 2023 representing a change of 50.66%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Earnings per Share (EPS): EPS increased to 2.17 in 2024 from 2.17 in 2023 representing a change of 79.34%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q3	Q/Q change %
0001375365
revenue	5308192000	3850066000	37.87
gross profit	596348000	597368000	-0.17
gross profit ratio	0.11	0.16	-27.59
research and development expenses	126849000	116226000	9.14
operating expenses	252944000	219054000	15.47
interest income	0	0	NaN
interest expense	0	6246000	-100.00
ebitda	357359000	388713000	-8.07
ebitdaratio	0.07	0.1	-33.32
operating income	343404000	378314000	-9.23
operating income ratio	0.06	0.1	-34.16
net income	352727000	402459000	-12.36
net income ratio	0.07	0.1	-36.43
eps	0.6	0.71	-15.49

Overall Score of Quarterly Income Statement

0.25 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 5,308 million in 2024Q4 from 3,850 million in 2024Q3 representing a change of 37.87%. This indicates a sales growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 127 million in 2024Q4 from 116 million in 2024Q3 representing a change of 9.14%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 596 million in 2024Q4 from 597 million in 2024Q3 representing a change of -0.17%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 253 million in 2024Q4 from 219 million in 2024Q3 representing a change of 15.47%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 357 million in 2024Q4 from 389 million in 2024Q3 representing a change of -8.07%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 343 million in 2024Q4 from 378 million in 2024Q3 representing a change of -9.23%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 353 million in 2024Q4 from 402 million in 2024Q3 representing a change of -12.36%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.6 in 2024Q4 from 0.6 in 2024Q3 representing a change of -15.49%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001375365
total assets	9943240000	3674729000	170.58
total liabilities	4473580000	1702559000	162.76
total equity	5469660000	1972170000	177.34
cash and cash equivalents	1669766000	440459000	279.10
short term investments	0	100000	-100.00
long term investments	0	-1800000	100.00
total current assets	9054624000	3179426000	184.79
total non current assets	888616000	495303000	79.41
total current liabilities	2403945000	1374652000	74.88
total non current liabilities	2069635000	327907000	531.17
common stock	2827627000	538352000	425.24
retained earnings	2641163000	1433014000	84.31
total debt	2174145000	290302000	648.93

Overall Score of Annual Balance Sheet

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 9,943 million in 2024 from 3,675 million in 2023 representing a change of 170.58%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 5,470 million in 2024 from 1,972 million in 2023 representing a change of 177.34%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,670 million in 2024 from 440 million in 2023 representing a change of 279.1%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 9,055 million in 2024 from 3,179 million in 2023 representing a change of 184.79%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 2,828 in 2024 from 538 in 2023 representing a change of 425.24%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 2,641 million in 2024 from 1,433 million in 2023 representing a change of 84.31%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 4,474 million in 2024 from 1,703 million in 2023 representing a change of 162.76%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 0 million in 2024 from 0 million in 2023 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 2,404 million in 2024 from 1,375 million in 2023 representing a change of 74.88%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 2,174 million in 2024 from 290 million in 2023 representing a change of 648.93%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q3	Q/Q change %
0001375365
total assets	9943240000	8862781000	12.19
total liabilities	4473580000	3768625000	18.71
total equity	5469660000	5094156000	7.37
cash and cash equivalents	1669766000	2115476000	-21.07
short term investments	0	100000	-100.00
long term investments	0	0	NaN
total current assets	9054624000	8063932000	12.29
total non current assets	888616000	798849000	11.24
total current liabilities	2403945000	1717695000	39.95
total non current liabilities	2069635000	2050930000	0.91
common stock	2827627000	2805008000	0.81
retained earnings	2641163000	2288436000	15.41
total debt	2174145000	1871621000	16.16

Overall Score of Quarterly Balance Sheet

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 9,943 million in 2024Q4 from 8,863 million in 2024Q3 representing a change of 12.19%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 5,470 million in 2024Q4 from 5,094 million in 2024Q3 representing a change of 7.37%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 9,055 million in 2024Q4 from 8,064 million in 2024Q3 representing a change of 12.29%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 2,828 in 2024Q4 from 2,805 in 2024Q3 representing a change of 0.81%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 2,641 million in 2024Q4 from 2,288 million in 2024Q3 representing a change of 15.41%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 4,474 million in 2024Q4 from 3,769 million in 2024Q3 representing a change of 18.71%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 1,670 million in 2024Q4 from 2,115 million in 2024Q3 representing a change of -21.07%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 0 million in 2024Q4 from 0 million in 2024Q3 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 2,404 million in 2024Q4 from 1,718 million in 2024Q3 representing a change of 39.95%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 2,174 million in 2024Q4 from 1,872 million in 2024Q3 representing a change of 16.16%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001375365
net change in cash	1229313000	172401000	613.05
operating cash flow	-2479437000	663580000	-473.65
free cash flow	-2479437000	626787000	-495.58
capital expenditure	0	-36793000	100.00
depreciation and amortization	0	34904000	-100.00
deferred income tax	0	-92969000	100.00
stock based compensation	228199000	54433000	319.23
accounts payables	0	127135000	-100.00
inventory	0	100042000	-100.00
acquisitions net	0	-2193000	100.00
investments in property plant and equipment	0	-36793000	100.00
net cash used for investing activites	-200783000	-39486000	-408.49
debt repayment	0	-300564000	100.00
common stock issued	0	0	NaN
common stock repurchased	0	-149998000	100.00
dividends paid	0	0	NaN
net cash used provided by financing activities	3911724000	-448293000	972.58
cash at end of period	1670273000	440960000	278.78
accounts receivables	0	-311897000	100.00
cash at beginning of period	440960000	268559000	64.19

Overall Score of Annual Cashflow Statement

0.25 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 1,229 million in 2024 from 172 million in 2023 representing a change of 613.05%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024 from 127 million in 2023 representing a change of -100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to -2,479 million in 2024 from 664 million in 2023 representing a change of -473.65%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -2,479 million in 2024 from 627 million in 2023 representing a change of -495.58%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to 0 million in 2024 from -37 million in 2023 representing a change of 100.0%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2024 from -93 million in 2023 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 228 million in 2024 from 54 million in 2023 representing a change of 319.23%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 0 in 2024 from -312 million in 2023 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q3	Q/Q change %
0001375365
operating cash flow	-635279000	-1519538000	58.19
free cash flow	-524983000	-1612483000	67.44
capital expenditure	110296000	-92945000	218.67
depreciation and amortization	0	10399000	-100.00
deferred income tax	0	-88865000	100.00
stock based compensation	71652000	56107000	27.71
accounts receivables	507870000	-153185000	431.54
accounts payables	0	-170000000	100.00
inventory	2679023000	-1657590000	261.62
acquisitions net	0	0	NaN
investments in property plant and equipment	110296000	-92945000	218.67
net cash used for investing activites	-68814000	-109434000	37.12
debt repayment	0	1494332000	-100.00
common stock issued	0	1731186000	-100.00
common stock repurchased	-2339104000	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	0	3020589000	-100.00
net change in cash	-445709000	1389916000	-132.07
cash at end of period	1670273000	2115376000	-21.04
cash at beginning of period	2115982000	725460000	191.67

Overall Score of Quarterly Cashflow Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -446 million in 2024Q4 from 1,390 million in 2024Q3 representing a change of -132.07%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to 110 million in 2024Q4 from -93 million in 2024Q3 representing a change of 218.67%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2024Q4 from -89 million in 2024Q3 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 72 million in 2024Q4 from 56 million in 2024Q3 representing a change of 27.71%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 508 in 2024Q4 from -153 million in 2024Q3 representing a change of 431.54%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to -635 million in 2024Q4 from -1,520 million in 2024Q3 representing a change of 58.19%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to -525 million in 2024Q4 from -1,612 million in 2024Q3 representing a change of 67.44%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024Q4 from 170 million in 2024Q3 representing a change of 100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q1 2025 Earnings call transcript
Q4 2024 Earnings call transcript
Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-06-30	2023-06-30	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	26.88	13.46	99.72
net income per share	2.17	1.21	79.73
operating cash flow per share	-4.46	1.25	-455.75
free cash flow per share	-4.46	1.18	-476.63
cash per share	3.0	0.83	260.85
book value per share	9.84	3.73	164.06
tangible book value per share	9.84	3.72	164.30
shareholders equity per share	9.84	3.73	164.07
interest debt per share	3.95	0.57	594.30
market cap	45154132400	13194202500	242.23
enterprise value	45658511400	13044045500	250.03
pe ratio	37.37	20.62	81.29
price to sales ratio	3.02	1.85	63.14
pocfratio	-18.21	19.88	-191.59
pfcf ratio	-18.21	21.05	-186.51
pb ratio	8.26	6.69	23.39
ptb ratio	8.26	6.69	23.39
ev to sales	3.06	1.83	66.87
enterprise value over ebitda	35.44	16.39	116.27
ev to operating cash flow	-18.41	19.66	-193.68
ev to free cash flow	-18.41	20.81	-188.49
earnings yield	0.03	0.05	-44.84
free cash flow yield	-0.05	0.05	-215.59
debt to equity	0.4	0.15	170.02
debt to assets	0.22	0.08	176.78
net debt to ebitda	0.39	-0.19	307.54
current ratio	3.77	2.31	62.85
interest coverage	65.4	72.55	-9.85
income quality	-2.05	1.04	-297.93
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.01	0.01	-7.33
research and ddevelopement to revenue	0.03	0.04	-28.18
intangibles to total assets	0	0.0	-100.00
capex to operating cash flow	0	0.06	-100.00
capex to revenue	0	0.01	-100.00
capex to depreciation	0	1.05	-100.00
stock based compensation to revenue	0.02	0.01	99.85
graham number	21.94	10.07	117.86
roic	0.16	0.29	-45.17
return on tangible assets	0.12	0.17	-30.27
graham net net	2.52	0.61	314.42
working capital	6650679000	1804774000	268.50
tangible asset value	5469660000	1970370000	177.60
net current asset value	4581044000	1476867000	210.19
invested capital	7064687000	2096814000	236.92
average receivables	1908337000	991386000	92.49
average payables	1160940500	716117000	62.12
average inventory	2926768000	1495585000	95.69
days sales outstanding	65.18	58.84	10.78
days payables outstanding	43.95	48.55	-9.47
days of inventory on hand	125.39	90.34	38.80
receivables turnover	5.6	6.2	-9.73
payables turnover	8.3	7.52	10.46
inventory turnover	2.91	4.04	-27.95
roe	0.22	0.32	-31.94
capex per share	0	0.07	-100.00

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.22 on 2024-06-30 from 0.32 on 2023-06-30, representing a change of -31.94%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.40 on 2024-06-30 from 0.15 on 2023-06-30, representing a change of 170.02%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 37.37 on 2024-06-30 from 20.62 on 2023-06-30, representing a change of 81.29%. Indicating an increase in the relative valuation of the company's stock.

• Negative

  Current Ratio: Current Ratio increased to 3.77 on 2024-06-30 from 2.31 on 2023-06-30, representing a change of 62.85%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Quarterly Financial Ratios

	2024-06-30 Q4	2024-03-31 Q3	Q/Q change %
SMCI
calendar year	2024	2024	NaN
revenue per share	9.04	6.82	32.68
net income per share	0.6	0.71	-15.66
operating cash flow per share	-1.08	-2.69	59.77
free cash flow per share	-0.89	-2.86	68.67
cash per share	2.85	3.75	-24.04
book value per share	9.32	9.02	3.33
tangible book value per share	9.32	9.02	3.33
shareholders equity per share	9.32	9.02	3.33
interest debt per share	3.7	3.31	11.90
market cap	47672262400	58578981600	-18.62
enterprise value	48176641400	58335126600	-17.41
pe ratio	33.79	36.39	-7.14
price to sales ratio	8.98	15.22	-40.97
pocfratio	-75.04	-38.55	-94.66
pfcf ratio	-90.81	-36.33	-149.96
pb ratio	8.72	11.5	-24.21
ptb ratio	8.72	11.5	-24.21
ev to sales	9.08	15.15	-40.10
enterprise value over ebitda	134.81	150.07	-10.17
ev to operating cash flow	-75.84	-38.39	-97.54
ev to free cash flow	-91.77	-36.18	-153.66
earnings yield	0.01	0.01	7.69
free cash flow yield	-0.01	-0.03	59.99
debt to equity	0.4	0.37	8.66
debt to assets	0.22	0.21	3.99
net debt to ebitda	1.41	-0.63	324.98
current ratio	3.77	4.69	-19.77
interest coverage	0	60.57	-100.00
income quality	-1.8	-3.78	52.30
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.01	0.01	-3.97
research and ddevelopement to revenue	0.02	0.03	-20.84
intangibles to total assets	0	0	NaN
capex to operating cash flow	-0.17	-0.06	-183.84
capex to revenue	0.02	0.02	-13.93
capex to depreciation	0	8.94	-100.00
stock based compensation to revenue	0.01	0.01	-7.37
graham number	11.23	12.03	-6.65
roic	0.04	0.06	-21.70
return on tangible assets	0.04	0.05	-21.88
graham net net	2.39	2.92	-18.10
working capital	6650679000	6346237000	4.80
tangible asset value	5469660000	5094156000	7.37
net current asset value	4581044000	4295307000	6.65
invested capital	7064687000	6731803000	4.94
average receivables	2159284000	1576562000	36.96
average payables	1318747500	1176989000	12.04
average inventory	4266279500	3295792000	29.45
days sales outstanding	45.24	38.57	17.29
days payables outstanding	29.51	30.23	-2.37
days of inventory on hand	84.2	114.12	-26.22
receivables turnover	1.99	2.33	-14.74
payables turnover	3.05	2.98	2.42
inventory turnover	1.07	0.79	35.55
roe	0.06	0.08	-18.37
capex per share	0.19	0.16	14.20

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 33.79 on 2024-06-30 Q4 from 36.39 on 2024-03-31 Q3, representing a change of -7.14%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 3.77 on 2024-06-30 Q4 from 4.69 on 2024-03-31 Q3, representing a change of -19.77%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.40 on 2024-06-30 Q4 from 0.37 on 2024-03-31 Q3, representing a change of 8.66%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None